162 related articles for article (PubMed ID: 1858377)
21. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
[TBL] [Abstract][Full Text] [Related]
22. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of various screening and surveillance methods in colorectal carcinoma].
Burchert A; Schmassmann A
Schweiz Med Wochenschr; 1998 Jun; 128(25):999-1011. PubMed ID: 9691335
[TBL] [Abstract][Full Text] [Related]
24. [Repeat screening for colorectal carcinoma in a population of asymptomatic individuals after 2 years].
Zoubek V; Zoubková H
Cas Lek Cesk; 1989 Apr; 128(15):463-4. PubMed ID: 2736588
[TBL] [Abstract][Full Text] [Related]
25. The importance of self-observation of fecal blood in indicating a proper bowel examination.
Hákkinen IP; Nylamo EI; Sóderstróm KO
Cancer Detect Prev; 1997; 21(3):267-72. PubMed ID: 9167044
[TBL] [Abstract][Full Text] [Related]
26. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
27. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history.
Rex DK; Lehman GA; Ulbright TM; Smith JJ; Pound DC; Hawes RH; Helper DJ; Wiersema MJ; Langefeld CD; Li W
Am J Gastroenterol; 1993 Jun; 88(6):825-31. PubMed ID: 8503374
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.
Reilly JM; Ballantyne GH; Fleming FX; Zucker KA; Modlin IM
Am Surg; 1990 Mar; 56(3):119-23. PubMed ID: 2316930
[TBL] [Abstract][Full Text] [Related]
29. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
30. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
31. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
Musil D; Tillich J
Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
33. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary report about the screening program for colorectal cancer by sequential fecal occult blood in Wuhan area for 4 years].
Lu ZM; Chen JG; Zhang YX; Wang Q; Xu J; Chen C; Yang R; Xiong F; Liu C; Peng XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):474-6. PubMed ID: 19742337
[TBL] [Abstract][Full Text] [Related]
35. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
Loss J; Eichhorn C; Nagel E
Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
[TBL] [Abstract][Full Text] [Related]
36. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
[TBL] [Abstract][Full Text] [Related]
37. Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience.
Matarese VG; Feo CV; Pezzoli A; Trevisani L; Brancaleoni M; Gullini S
Eur J Cancer Prev; 2007 Aug; 16(4):292-7. PubMed ID: 17554201
[TBL] [Abstract][Full Text] [Related]
38. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
39. [The screening model for early diagnosis of colorectal cancer in general population].
Zheng S
Zhonghua Yi Xue Za Zhi; 1991 Jul; 71(7):381-4, 28. PubMed ID: 1659480
[TBL] [Abstract][Full Text] [Related]
40. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]